Suchergebnisse - "Goletti, Delia"

PubPharm (402)

101

Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021

von Aiello, A. | Najafi Fard, S. | Petruccioli, E. | +10

102

In-vitro evaluation of the immunomodulatory effects of Baricitinib : Implication for COVID-19 therapy

enthalten in: The Journal of infection | 2021

von Petrone, L. | Petruccioli, E. | Alonzi, T. | +15

103

Inhibition of HECT E3 ligases as potential therapy for COVID-19

enthalten in: Cell death & disease | 2021

von Novelli, G. | Liu, J. | Biancolella, M. | +40

104

Concurrent cavitary pulmonary tuberculosisand COVID-19 pneumonia with in vitro immune cell anergy:a case report.

enthalten in: ResearchSquare.com | 2021

von Musso, M. | Gennaro, F. | Gualano, G. | +9

105

Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic : Data from an Italian Infectious Disease Referral Hospital

enthalten in: Antibiotics (Basel, Switzerland) | 2021

von Di Gennaro, F. | Gualano, G. | Timelli, L. | +17

106

Baricitinib Therapy in Covid-19 Pneumonia - An Unmet Need Fulfilled

enthalten in: The New England journal of medicine | 2021

von Goletti, D. | Cantini, F.

CommentOn: N Engl J Med. 2021 Mar 4;384(9):795-807. - PMID 33306283

107

Down Syndrome patients with COVID-19 pneumonia : A high-risk category for unfavourable outcome

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021

von Vita, S. | Di Bari, V. | Corpolongo, A. | +90

108

A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Petrone, L. | Petruccioli, E. | Vanini, V. | +17

109

PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease

enthalten in: Frontiers in immunology | 2021

von Grassi, G. | Vanini, V. | De Santis, F. | +14

110

Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy

enthalten in: Infection | 2021

von Musso, M. | Di Gennaro, F. | Gualano, G. | +10